Entrada Therapeutics, Inc. (TRDA) Earnings Call Transcripts

9 earnings calls from June 2022 to June 8, 2026

NasdaqGM US Health Care Biotechnology

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. (TRDA) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 9 calls on record spanning June 14, 2022 to June 8, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 9 Entrada Therapeutics, Inc. earnings call transcripts on record, spanning June 14, 2022 to June 8, 2026. Based on this history, Entrada Therapeutics, Inc. reports semi-annually. The most recent call on file is dated June 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
TRDA
Exchange
NasdaqGM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
9
First call
June 14, 2022
Most recent
June 8, 2026
Reporting cadence
semi-annually
Quarter Date
Company Conference Presentations Jun 8, 2026 Read transcript →
Q1 FY2026 May 7, 2026 Read transcript →
Company Conference Presentations Jan 14, 2026 Read transcript →
Special Calls Sep 25, 2025 Read transcript →
Company Conference Presentations Jun 9, 2025 Read transcript →
Company Conference Presentations Jan 15, 2025 Read transcript →
Company Conference Presentations Jun 10, 2024 Read transcript →
Company Conference Presentations Jun 14, 2023 Read transcript →
Company Conference Presentations Jun 14, 2022 Read transcript →